Intraoperative Radiotherapy for Musculoskeletal Cancer
Author Information
Author(s): Xu Yao, Feng Zhe, Liu YongHeng, Feng JinYan, Zhang Yan, Zhang Chao, Han XiuXin, Xu LiMing, Wang GuoWen
Primary Institution: Tianjin Medical University Cancer Institute & Hospital
Hypothesis
The study aims to explore the effect of intraoperative radiotherapy (IORT) on the survival outcomes of patients with musculoskeletal malignancy.
Conclusion
IORT during surgery, combined with neoadjuvant/adjuvant radiotherapy, may improve survival for selected patients with musculoskeletal malignancy.
Supporting Evidence
- Patients receiving both IORT and neoadjuvant/adjuvant RT had the best survival outcomes.
- The median survival time for patients receiving IORT was 141.0 months.
- Subgroup analyses showed survival benefits for female patients and those with limb tumors.
Takeaway
This study looked at how a special type of radiation treatment given during surgery can help people with certain bone and soft tissue cancers live longer.
Methodology
A retrospective analysis of the SEER database from 2000 to 2020, comparing survival outcomes of patients receiving IORT versus those receiving traditional radiotherapy.
Potential Biases
Potential biases from the SEER database and the retrospective nature of the study.
Limitations
The study is limited by the retrospective design and lack of detailed information on IORT dose and resection margins.
Participant Demographics
Mean age of participants was 54.5 years, with a slight male predominance (53.6%).
Statistical Information
P-Value
p<0.05
Confidence Interval
95%CI: 101.1-180.9
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website